KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Non Operating Income: 2018-2025

Historic Non Operating Income for Acadia Pharmaceuticals (ACAD) over the last 7 years, with Sep 2025 value amounting to $593,000.

  • Acadia Pharmaceuticals' Non Operating Income rose 2.95% to $593,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.2 million, marking a year-over-year decrease of 578.52%. This contributed to the annual value of -$13.7 million for FY2024, which is 368.45% down from last year.
  • As of Q3 2025, Acadia Pharmaceuticals' Non Operating Income stood at $593,000, which was down 0.17% from $594,000 recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Non Operating Income ranged from a high of $4.8 million in Q1 2023 and a low of -$15.0 million during Q4 2024.
  • For the 3-year period, Acadia Pharmaceuticals' Non Operating Income averaged around -$683,100, with its median value being $582,000 (2024).
  • Its Non Operating Income has fluctuated over the past 5 years, first tumbled by 379.21% in 2022, then spiked by 1,325.00% in 2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Non Operating Income (Quarterly) stood at $2.2 million in 2021, then dropped by 28.27% to $1.5 million in 2022, then tumbled by 30.06% to $1.5 million in 2023, then plummeted by 61.80% to -$15.0 million in 2024, then climbed by 2.95% to $593,000 in 2025.
  • Its last three reported values are $593,000 in Q3 2025, $594,000 for Q2 2025, and $588,000 during Q1 2025.